Novocure · 6 days ago
Manager, HR Business Partner
Novocure is a company dedicated to extending the lives of people living with cancer. As a Manager, HR Business Partner, you will partner with leaders across North America to deliver people solutions that enhance team performance and foster an inclusive workplace.
BiotechnologyHealth CareMedical DeviceOncology
Responsibilities
Partner with functional leaders to support organizational design, workforce planning, and team effectiveness
Provide day-to-day guidance on talent priorities, helping leaders align people strategies with evolving business needs
Support change initiatives that enhance agility, engagement, and organizational effectiveness
Collaborate with HR Centers of Excellence to implement programs across talent acquisition, total rewards, DE&I, and learning & development
Support leadership and talent development initiatives, including succession planning, performance management, and feedback practices
Manage employee relations matters in partnership with Legal and Compliance, supporting a fair, inclusive, and compliant workplace
Use HR data and insights to inform decisions, identify trends, and contribute to continuous improvement of HR processes
Qualification
Required
Experience partnering with business leaders as an HR business partner in a dynamic organization
Demonstrated capability supporting organizational change, workforce planning, and talent development initiatives
Strong relationship-building, communication, and influencing skills across multiple levels
Solid knowledge of core HR disciplines, including performance management, employee relations, and talent development
Preferred
Experience within life sciences, biotech, or pharmaceutical environments
Experience collaborating across HR Centers of Excellence in a matrixed organization
A collaborative, solutions-oriented approach with a commitment to inclusive and high-performing teams
Benefits
Annual bonus
Restricted stock unit grant
Full range of benefits
Company
Novocure
An Oncology Company Pioneering a Novel Therapy for Solid Tumors
Funding
Current Stage
Public CompanyTotal Funding
$1BKey Investors
Pharmakon AdvisorsJP Morgan ChaseBioPharma Credit
2024-05-02Post Ipo Debt· $100M
2020-11-09Post Ipo Debt· $150M
2020-11-05Post Ipo Debt· $575M
Recent News
2026-01-13
2026-01-03
Company data provided by crunchbase